Diabetes Treatment: How Abbott Plans To Rival Dexcom With A New Device – Investor's Business Daily

Business News

  1. Diabetes Treatment: How Abbott Plans To Rival Dexcom With A New Device  Investor’s Business Daily
  2. Abbott’s Bluetooth-Enabled Glucose Monitor Finally Clears FDA Hurdle  Motley Fool
  3. 2 Million Patients And Beyond: Abbott’s FreeStyle Libre 2 Cleared In The U.S. For Adults And Children With Diabetes  Forbes
  4. FDA Clears Next-Generation Libre Glucose Monitor for Diabetes  Medscape
  5. Abbott’s (ABT) FreeStyle Libre Study Outcome Favorable  Yahoo Finance
  6. View Full Coverage on Google News

Source: Business News

/by